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Abstract
Nutrigenomics is a new application of omics technologies in nutritional science. Nutrigenomics aims to iden-
tify molecular markers of diet-related diseases and mechanisms of interindividual variability in response to
food. The aim of this study was to evaluate peripheral blood mononuclear cells (PBMC) as a model system and
readily available source of RNA to discern gene expression signatures in relation to personalized therapy of
obesity. PBMC were collected from obese men before and after an 8-week low-calorie diet (LCD) to lose weight.
Changes in gene expression before and after the LCD were initially screened using a DNA-microarray plat-
form and validated by qRT-PCR. Global gene expression analysis identified 385 differentially expressed tran-
scripts after the LCD. Further analyses showed a decrease in some specific oxidative stress and inflammation
genes. Interestingly, expression of these genes was directly related to body weight, while a lower IL8 gene ex-
pression was associated with higher fat mass decrease. Collectively, these observations suggest that PBMCs are
a suitable RNA source and model system to perform nutrigenomics studies related to obesity and development
of personalized dietary treatments. IL8 gene expression warrant further research as a putative novel biomarker
of changes in body fat percentage in response to an LCD.
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Introduction
UNDERSTANDING THE MOLECULAR BASIS involved in obesityand weight homeostasis is a crucial first step in devel-
oping therapeutic strategies against excess in body weight
gain (Sun, 2007; Viguerie et al., 2005a). Based on this, the
study of gene expression at the level of mRNA in response
to changing conditions, such as in nutritional intervention
studies (Kussmann et al., 2006), is being carried out by tran-
scriptomics, mainly using arrays (Heidecker and Hare, 2007;
Moreno-Aliaga et al., 2001). This new field, known as nu-
trigenomics, attempts to elucidate the impact of diet on gene
expression, whose long-term aim is personalized nutrition
for health maintenance and disease prevention (Kaput, 2008;
Mariman, 2006; Vakili and Caudill, 2007).
In this context, most gene expression studies in human
obesity are often focused on adipocytes, mainly on biopsed
subcutaneous adipose tissue (Hernandez-Morante et al.,
2008; Marrades et al., 2006; Viguerie et al., 2005a). Analysis
of visceral adipose tissue is basically restricted to morbid pa-
tients, whose tissue samples can be easily obtained during
surgery (Baranova et al., 2005). However, nutrigenomics
studies in humans have remained clearly insufficient to date
because it is difficult to obtain biopsies from every volunteer
involved in a nutritional study due to the invasive sample
collection procedure (Kussmann et al., 2006).
Molecular mechanisms underlying several human dis-
eases have been investigated by gene expression analysis of
peripheral blood mononuclear cells (PBMC) as surrogates for
predicting potential effects in tissues that are not easily ac-
cessible (Eady et al., 2005). These cells have been proposed
as a useful tool to better understand multiple sclerosis re-
lated pathways (Achiron and Gurevich, 2006), the patho-
physiology of Alzheimer’s disease (Maes et al., 2006), hepatic
diseases (Chiappini et al., 2006; Patalay et al., 2005), oncol-
ogy (DePrimo et al., 2003; Twine et al., 2003), and cardio-
vascular research (Horwitz et al., 2004). Also, peripheral
blood mononuclear cells (PBMC) were suggested as a sur-
rogate tissue to muscle biopsies to study mitochondrial dys-
function (Abu-Amero and Bosley, 2005; Marriage et al.,
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2003). The suitability of PBMCs for nutrigenomics studies is
in part related to their active metabolism (Kussmann et al.,
2006) and accessibility by a simple venipuncture (Liew et al.,
2006; Marriage et al., 2003), which may also permit repeated
time-series analysis of changes in gene expression in re-
sponse to food-related interventions. Interestingly, a re-
markable concordance (80%) of gene expression profiles
between PBMC and different tissues has been demonstrated
(Liew et al., 2006). Therefore, transcriptome analysis of pe-
ripheral blood is a promising approach for determining dis-
ease and treatment outcome (Debey et al., 2006). Based on
these considerations, the aim of the present study was to in-
vestigate whether PBMC gene expression is a suitable model
system to carry out nutrigenomics studies in human obesity.
Moreover, we evaluated PBMC gene expression signatures
to identify biomarkers that could predict individual differ-
ences in weight loss after a low-calorie diet (LCD).
Subjects and Methods
Subjects
The study was carried out in Caucasian obese men (n 
9) carefully recruited to participate as volunteers (Table 1).
Initial screening evaluations included a medical history,
physical examination, and fasting blood profile to exclude
subjects with clinical evidence of diabetes, hypertension,
liver, renal or hematological disease, or other disorders that
could interfere with the weight-loss process. Such features
were tested by a specifically trained physician. Other exclu-
sion criteria were weight change 3 kg within the 3 months
before the start of the study, participation in another scien-
tific study up to 1 month before, drug administration, preg-
nancy, surgical or drug-obesity treatment, or alcohol or drug
abuse.
After a clear explanation of the study, all subjects gave
their written informed consent to participate, which was pre-
viously approved by the Ethics Committee of the University
of Navarra (54/2006), in agreement with the Helsinki Dec-
laration.
Study design
The nutritional treatment involved an 8-week LCD, in
which the energy restriction was set up at 35% with re-
spect to the total energy expenditure of each participant cal-
culated by Harris-Benedict equation after applying the
WHO’s correction factor on physical activity [OMS (WHO),
2000]. The LCD was balanced for macronutrients (55% of en-
ergy as carbohydrates, 15% as proteins, and 30% as fat). The
menus were fixed following a dietary framework based on
a food exchange system (Crujeiras et al., 2006, 2007; Trem-
blay et al., 1983). Each subject was provided with a detailed
diet plan to follow for the 8 weeks and met with a dietician
periodically. Weight loss was monitored weekly by a dieti-
cian, and the intake was controlled by 3-day weighted food
records (2 weekdays and 1 weekend day). Foods records
were performed during the week before the beginning of the
intervention (week 0), and during the week before the end
of the nutritional trial (week 8). These data provided infor-
mation about baseline intake and the adherence to the pre-
scribed diets. All subjects lost at least 5% of body weight as
a result of the hypocaloric diet. At baseline (day 0) and at
the end of the nutritional intervention (day 56), anthropom-
etry was measured, and blood samples were collected with
EDTA as anticoagulant to obtain the PBMC for gene ex-
pression analyses.
Blood pressure and nutritinal status assessment
Blood pressure was measured with a standard mercury
sphygmomanometer (Minimus II, Riester, Germany) after
the subject was quietly sitting for 5 min following OMS cri-
teria. Plasma levels of glucose and total cholesterol were
measured by specific colorimetric assays (Horiba ABX Di-
agnostics, Montpellier, France) using an automatized system
(COBAS MIRA, Roche, Basel, Switzerland).
Isolation of RNA from PBMC
The PBMC were isolated by differential centrifugation us-
ing the PMN medium (Axis Shield PoC AS, Oslo, Norway).
After PBS washing, the total RNA was extracted from PBMC
by the Trizol reagent method (Invitrogen, Carlsbad, CA).
Quantitation and purity of the RNA obtained were assessed
by UV spectrophotometry (Multiskan Spectrum, Thermo
Electron Corp., Finland). The RNA integrity was assesed us-
ing a 2100 Bioanalyzer instrument (Agilent Technologies,
Palo Alto, CA). Additionaly, RNA quality was also checked
on agarose gel electrophoresis.
Synthesis and labeling of cDNA
Fluorescently labeled cDNA was synthesized from 10 g
of each total RNA sample. Anchored oligo(dT)20 and
amino–allyl adducts (Sigma-Aldrich, St. Louis, MO) were
used in the first strand cDNA synthesis reaction. The re-
sulting amino modified cDNA was divided into two tubes,
and each replicate was labeled using either Cy3 or Cy5 flu-
orescent dyes (Amersham Biosciences, Piscataway, NJ), ac-
cording to manufacturers protocols for appropriate dye-
swap hybridizations.
Microarray hybridization and image acquisition
Samples were hybridized to the Human 1A Oligo Mi-
croarray Kit (V2) as described by the supplier (Agilent Tech-
nologies, Santa Clara, CA). Each single oligo microarray
comprises over 22,575 probes and spans conserved exons
across the targeted human full-length gene transcripts.
Specifically, this array represents about 20,000 well-charac-
terized, full-length human genes. This probe set is sourced
from the Incyte Foundation Database, RefSeq, and GenBank
databases.
RNA samples coming from PBMC that were taken before
and after the nutritional intervention were differentially la-
beled and cohybridized on microarray slides. Appropriate
dye-swap hybridizations (dye reversal) were also carried out
to minimize potential biases arising from differences in the
dyes. Microarrays were hybridized overnight at 60°C in 
hybridization chambers (Genetix, Boston, MA). After hy-
bridizations slides were washed and dried prior to scanning.
Microarray images were obtained by scanning each slide
in a Gene Pix 4100A scanner (Axon Instruments, Union City,
CA). Image quantitation was performed using associated
software GenePiX Pro 6.0 and median intensity background
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subtracted values for each spot were used in subsequent
analysis.
Normalization and data analysis
Scanned microarray images were first examined for visi-
ble defects and then checked for the fitness of the gridding.
When passed, the image file was analyzed to generate com-
posite data files. From this point on, analyses were carried
out using the GeneSpring GX software v 7.3.1 (Agilent Tech-
nologies).
To normalize data, intensity-dependent (LOWESS) nor-
malization was used to eliminate dye-related artefacts. Once
data were normalized, consecutive filtering steps were per-
formed to remove noise derived from absent genes, back-
ground, and nonspecific hybridizations.
A Student’s t-test was applied to select differentially ex-
pressed genes between both conditions (before and after nu-
tritional intervention). Comparisons were performed for
each gene, and genes with the most significant differential
expression (p-value cutoff  0.05) were returned. Addition-
ally, statistically selected genes were assigned into specific
Gene Ontology categories, as well as in KEGG associated
pathways in order to extract maximum biological informa-
tion. The GO ontologies provide a systematic language for
the consistent description of attributes of genes and gene
products in three key biological domains that are shared by
all organisms: molecular function, biological process, and
cellular component (The Gene Ontology Consortium, 2008).
MIAME ArrayExpress
The current microarray data have been curated and ac-
cepted in the ArrayExpress database. This is a public repos-
itory for microarray data, which is aimed at storing MIAME
(Minimum Information About Microarray Experiments) compli-
ant data in accordance with MGED (Microarray Gene Expres-
sion Data) recommendations. The ArrayExpress Data Ware-
house stores gene-indexed expression profiles from a curated
subset of experiments in the repository. Access to data con-
cerning thus study may be found at ArrayExpress Web page
(http://www.ebi.ac.uk/arrayexpress), with experiment ac-
cession number: E-MEXP-1055.
Quantitative real-time PCR
Quantitation of mRNA was performed using quantitative
real-time polymerase chain reaction (qRT-PCR) to confirm
microarray data. Extracted total RNA from all the subjects
was purified with DNase treatment by means of DNA-free
kit (Ambion, Austin TX) used as a template to generate first-
strand cDNA synthesis using M-MLY reverse transcriptase
as described by the manufacturer (Invitrogen). Quantitative
real-time PCR was performed using an ABI PRISM 7000 HT
Sequence Detection System as described by the provider
(Applied Biosystems, Foster City, CA). Taqman probes for
genes were supplied by Applied Biosystems and gene ex-
pression levels were normalized using 18S rRNA as internal
control, because this housekeeping gene does not change af-
ter the 8 weeks of low caloric diet, and it has been proved
in previous studies with PBMC (Ghanim et al., 2004).
Eleven genes were selected for PCR quantificantion ac-
cording to their association with the proinflammatory
and/or oxidative stress processes. These genes were selected
because of their importance in the respective metabolic path-
ways. Thus, regarding inflammation-related processes, all
the genes selected (TANK, TNFAIP8L1, TRIAD3, NKRF,
TNIP1, and RIPK3) are related to TNF/NF-B signalling
pathway, in addition to IL8. Regarding oxidative stress-re-
lated genes, some of them are involved in the mitochondr-
ial function (NDUFS2, COX15, and ACAA2), whereas others
are related to antioxidant defenses (MGST2).
Statistical analysis
The fold change in gene expression was calculated using
the 2Ct relative quantitation method, using the average
of Ct values after subtraction with Ct value of 18S from base-
line (Livak and Schmittgen, 2001; Milagro et al., 2007) ac-
cording to the manufacturer`s guidelines (Applied Biosys-
tems). The nonparametric Wilcoxon-paired test was applied
to detect differences before and after weight loss in anthro-
pometric measurements, as well as the expression levels of
selected genes. Data are reported as the mean  SD for an-
thropometric measurements and geometric mean (SEM as
range) for qRT-PCR results. Correlation analysis was per-
formed with Spearman rank order correlation. A p-value
0.05 was considered as statistically significant and a p-
value 0.1 as a trend for significance. Statistical analysis was
performed by SPSS 13.0 software (SPSS Inc. Chicago, IL) for
Windows XP (Microsoft, Redmond, WA).
Results
Owing to the energy restriction, all volunteers lost body
weight (8.9  1.5%), which was accompanied by a marked
decrease in body mass index (Table 1). The microarray com-
parison between before and after the nutritional intervention
resulted in 385 differentially expressed genes, with 158 genes
overexpresed and 227 genes downregulated after the LCD
treatment with respect to baseline before following the LCD.
As shown in Figure 1, genes encoding factors involved in
nucleotide, DNA, and chromatin metabolism, as well as in
cellular biosynthetic and regulation of metabolic processes,
including protein and lipid metabolic pathways, were mostly
upregulated (p  0.05), whereas those related to signal trans-
duction, cell communication, transport, immune response,
and carbohydrate metabolism were mostly downregulated
(p  0.05).
Gene ontology and pathway analysis (Table 2) showed
that the biological functions associated with carbohydrate,
lipid, and protein metabolism, oxidative phosphorylation,
immune response, and coagulation were affected by the
nutritional intervention. Moreover, after weight loss, other
genes involved in relevant metabolic pathways, such as
SIRT2, GHRL, RBP2, and SRF, were differentially expressed
(Table 2).
After analyzing microarray data, 11 oxidative stress and
inflammation-related genes were selected for qRT-PCR
quantification. Thus, although some genes related to the
TNF/NF-B signaling pathway did not change their ex-
pression, such as TANK, TNFAIP8L1, TRIAD3, and NKRF,
others, such as TNIP1 and RIPK3, as well as IL8, significantly
decreased after the LCD treatment (Table 3). Regarding ox-
idative stress related genes, NDUFS2 significantly decreased
the expression levels in PBMC, while no changes in MGST2,
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FIG. 1. Histograms showing some biological processes differentially regulated by weight loss in PBMC of obese subjects
treated by an 8-week low-caloric diet. (A) Some metabolic processes from levels 4 and 5 of Gene Ontology, which are stated
in the X-axis. (B) Other specific molecular functions belonging to levels 3 to 7 of Gene Ontology (GO), which are stated in
the X axis. In the Y-axis, the percentage of genes belonging to each biological process showed in the X-axis that are down-
or upregulated by the caloric restriction treatment, is represented compared to the total number of genes of each biologi-
cal process that are present in the microarray.
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TABLE 2. SELECTED GENES AND PATHWAYS OF INTEREST CONCERNING CHANGES IN
PBMC GENE EXPRESSION PROFILING LIST AFTER WEIGHT LOSS
Pathways and Genes Gene symbol GenBank ID Fold change
Protein metabolism
Solute carrier family 7 SLC7A4 NM_004173 0.78  0.05
Gamma-glutamyltransferase-like activity 1 GGTLA1 NM_004121 0.71  0.16
Homogentisate 1,2-dioxygenase HGD NM_000187 0.89  0.05
Acireductone dioxygenase 1 MTCBP-1 NM_018269 1.30  0.27
Glutaminase 2 GLS2 NM_013267 1.31  0.34
Nitrogen fixation 1 homolog NFS1 NM_021100 1.50  0.41
Carbohydrate metabolism
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 ST6GAL2 NM_032528 0.58  0.18
Alcohol dehydrogenase IB ADH1B NM_000668 0.73  0.19
Ribose 5-phosphate isomerase A RPIA NM_144563 0.84  0.11
Glycogenin 2 GYG2 NM_003918 0.77  0.19
Insulin receptor substrate 2 IRS2 NM_003749 0.87  0.11
Xylosyltransferase II XYLT2 NM_022167 1.11  0.05
Hyaluronoglucosaminidase 1 HYAL1 NM_007312 1.21  0.16
Fucosyltransferase 8 FUT8 NM_178154 1.28  0.24
Lactate dehydrogenase D LDHD NM_153486 1.27  0.31
Lipid metabolism
Apolipoprotein C-I APOC1 NM_001645 0.84  0.08
Very low density lipoprotein receptor VLDLR NM_003383 0.88  0.06
Acetyl-Coenzyme A acyltransferase 2 ACAA2 NM_006111 1.26  0.15
Acyl-CoA synthetase long-chain family member 5 ACSL5 NM_203380 1.24  0.23
Phospholipase A2, group XIIB PLA2G12B NM_032562 1.42  0.41
Patatin-like phospholipase domain containing 3 ADPN NM_025225 0.66  0.21
Gamma-glutamyltransferase-like activity 1 GGTLA1 NM_004121 0.71  0.16
Pancreatic lipase-related protein 1 PNLIPRP1 NM_006229 0.75  0.18
Apolipoprotein L, 1 APOL1 NM_145344 0.84  0.12
24-dehydrocholesterol reductase DHCR24 NM_014762 1.05  0.05
Sphingosine kinase 1 SPHK1 NM_021972 1.27  0.28
Fatty acid transport protein 4 SLC27A4 AF055899 0.98  0.61
Microsomal glutahione S-transferase 2 MGST2 NM_002413 1.28  0.32
Oxidative Phosphorilation
ATPase, H	 transporting, lysosomal V0 subunit a4 ATP6V0A4 NM_020632 0.74  0.10
Cytochrome c oxidase assembly protein COX15 NM_078470 0.68  0.21
NADH-coenzyme Q reductase NDUFS2 NM_004550 0.77  0.18
Cytochrome b-561 CYB561 NM_001017916 1.15  0.12
Immune Response
T-cell activation antigen CD26 DPP4 NM_001935 0.79  0.10
Tumor necrosis factor related protein 4 C1QTNF4 NM_031909 0.88  0.04
TNFAIP3 interacting protein 1 TNIP1 NM_006058 0.92  0.06
Tumor necrosis factor (ligand) superfamily, member 8 TNFSF8 NM_001244 0.86  0.12
T-cell surface glycoprotein CD8 beta chain CD8B1 NM_172099 1.09  0.10
Rho-related GTP-binding protein RHOH NM_004310 1.14  0.13
Tumor necrosis factor, alpha-induced protein 8-like1 TNFAIP8L1 NM_152362 1.33  0.37
Bloom syndrome protein BLM NM_000057 1.54  0.72
Interferon, alpha 16 IFNA16 NM_002173 1.85  0.85
Interleukin-1 receptor-associated kinase 4 IRAK4 NM_016123 0.68  0.16
Coagulation factor III (thromboplastin, tissue factor) F3 NM_001993 0.71  0.13
Prostate associated gene 1 PAGE1 NM_003785 0.67  0.18
Killer cell lectin-like receptor subfamily A KLRA1 NM_006611 0.68  0.20
T-cell receptor T3 gamma chain CD3G NM_000073 0.78  0.15
B-lymphocyte antigen CD19 CD19 NM_001770 0.77  0.16
ATP-binding cassette transporter TAP1 NM_000593 0.84  0.09
CD24 molecule CD24 NM_013230 0.88  0.07
Adenosine deaminase, RNA-specific ADAR NM_001111 0.82  0.15
Interferon, alpha-inducible protein 6 G1P3 NM_022873 1.12  0.11
Oral-facial-digital syndrome 1 OFD1 NM_003611 1.23  0.24
Microsomal glutahione S-transferase 2 MGST2 NM_002413 1.28  0.32
Bradykinin receptor B1 BDKRB1 NM_000710 1.52  0.64
Interleukin 8 IL8 NM_000584 1.32  1.07a
COX15, and ACAA2 were found after the weight loss in-
duced by a LCD (Table 3).
A consistent positive correlation was detected among
mRNA levels of some of the genes studied (Table 4). Thus,
RIPK3 was highly associated with TANK, TNIP1, and
TRIAD3, all of them in the TNF /NF-B pathway. TNIP
was also related to other genes of this pathway, such as
TANK and TRIAD3, while TNFAIP8L1 was correlated with
NKRF and TANK, suggesting that these genes share the same
regulatory pathway.
On the other hand, the oxidative stress-related genes were
also associated each other and with the inflammation-related
genes (Table 4). Finally, significant correlations were found
between body weight and mRNA expression of TNIP (r 
0.62; p  0.006) and TANK (r  0.53; p  0.023), and NDUFS2
tended to be correlated (r  0.40; p  0.098), before and af-
ter caloric restriction treatment (n  18). While, TRIAD3
mRNA levels (r  74; p  0.037) after the intervention were
associated with body weight at this point, together a trend
for a correlation in the ACAA2 transcripts (r  0.64; p 
0.066). Interestingly, a lower IL8 gene expression after LCD
was associated with higher fat mass decrease (Fig. 2).
Discussion
The impact of nutrition on gene expression is being ex-
plored in the obesity domain because nutrigenomics ap-
proach could be applied to personalize nutrition (Kaput, 2008;
Ronteltap et al., 2008). In this context, technologies involved 
in DNA microarrays make it possible to assess the effect of
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TABLE 2. SELECTED GENES AND PATHWAYS OF INTEREST CONCERNING CHANGES IN
PBMC GENE EXPRESSION PROFILING LIST AFTER WEIGHT LOSS (CONT’D)
Pathways and Genes Gene symbol GenBank ID Fold change
NF-kappa-B-responsive genes
TRIAD 3 protein TRIAD3 NM_207111 0.77  0.10
Receptor-interacting serine-threonine kinase 3 RIPK3 NM_006871 0.68  0.22
NF-kappaB repression factor NKRF NM_017544 0.84  0.10
TNFAIP3 interacting protein 1 TNIP1 NM_006058 0.92  0.06
TRAF (tumor necrosis factor receptor-associated factor) TANK NM_004180 1.09  0.08
family member-associated NF-kappaB activator
Coagulation
Coagulation factor III (thromboplastin, tissue factor) F3 NM_001993 0.71  0.13
Vitamin K-dependent gamma-carboxylase GGCX NM_000821 0.68  0.22
Other Genes
Ghrelin GHRL NM_016362 0.79  0.15
Sirtuin SIRT2 NM_012237 1.18  0.11
c-Fos serum response element-binding transcription SRF NM_003131 1.37  0.37
factor
Retinol binding protein 2 RBP2 NM_004164 1.51  0.69
All the genes in this list were significantly up- or down-regulated (p  0.05) when analyzing the microarray by Student’s t-test except for
those marked with (a).
TABLE 3. EXPRESSION CHANGES FROM SELECTED GENES IN PBMC ASSESSED BY QRT-PCR 
AFTER WEIGHT LOSS INDUCED BY A LCD IN OBESE VOLUNTEERS.
Gene symbol GenBank ID qRT-PCR p-value
Inflammation-related genes
RIPK3 NM_006871 0.72 (0.62–0.85) 0.086
TNIP1 NM_006058 0.70 (0.63–0.78) 0.021
NKRF NM_017544 0.90 (0.74–1.09) 0.314
TANK NM_004180 0.85 (0.71–1.01) 0.441
TRIAD3 NM_207111 0.85 (0.72–0.99) 0.263
TNFAIP8L1 NM_152362 0.87 (0.70–1.09) 0.314
IL8 NM_000584 0.46 (0.29–0.73) 0.066
Oxidative stress-related genes
ACAA2 NM_006111 1.03 (0.78–1.20) 0.678
COX15 NM_078470 0.91 (0.73–1.14) 0.678
NDUFS2 NM_004550 0.71 (0.63–0.80) 0.021
MGST2 NM_002413 1.19 (1.02–1.39) 0.374
mRNA levels were normalized to 18S. Fold changes were evaluated using the 2Ct method of relative quantification above the expres-
sion levels of before low calorie treatment state (set at unity). Data are reported as geometric mean (S.E.M as a range).
a specific diet or nutrient on the expression of a large num-
ber of genes (Afman and Muller, 2006; Kussmann et al., 2006;
Puskas et al., 2006). Recent examples of this approach show
differential gene expression profiling during nutritional in-
tervention both in animal models (Campion et al., 2006;
Lopez et al., 2003) or in human biopsies of adipose tissue
(Baranova et al., 2005; Clement et al., 2004; Viguerie et al.,
2005a). However, few studies have been performed in hu-
mans, where an important barrier to identify molecular bio-
markers is the inaccessibility to tissue samples (Muller and
Kersten, 2003). It would be useful to find a noninvasive
source of RNA to explore the role of gene expression in the
context of human diet intervention studies. Thus, the gene
expression differences in normal individuals has suggested
the power of the gene expression in PBMC to study the vari-
ation in populations that may account for differences in dis-
ease incidence and treatment response (Radich et al., 2004).
Accordingly, some authors have recently studied the re-
sponses to dietary exposure by analyzing the gene expres-
sion profile in blood cells, suggesting that this kind of sam-
ple could be applied to perform nutrigenomics studies (van
Erk et al., 2006). Moreover, a previous study showed 35 com-
mon genes downregulated both in adipose tissue and PBMC
from controls compared to obese (García-Amigot et al., 2005).
In this sense, the current experimental study has specifically
utilized PBMC samples, collected by simple blood extraction,
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TABLE 4. SPEARMAN RANK ORDER CORRELATION ANALYSIS BETWEEN THE EXPRESSION OF THE EVALUATED GENES
Inflammation-related genes Oxidative stress-related genes
TNIP1 NKRF TANK TRIAD3 TNFAIP8L1 IL8 ACAA2 COX15 NDUFS2 MGST2
RIPK3 0.68c 0.38 0.83b 0.71c 0.55 0.43 0.80c 0.69c 0.80c 0.79c
TNIP1 0.60 0.82b 0.76c 0.58 0.30 0.73c 0.38 0.60 0.60
NKRF 0.32 0.83c 0.93a 0.33 0.72c 0.56 0.27 0.18
TANK 0.79c 0.48 0.17 0.73c 0.59 0.93b 0.88b
TRIAD3 0.90b 0.48 0.90b 0.76c 0.68c 0.50
TNFAIP8L1 0.28 0.85b 0.74c 0.50 0.35
IL8 0.48 0.33 0.033 0.08
ACAA2 0.83‡ 0.68c 0.53
COX15 0.73c 0.59
NDUFS2 0.93a
Data showed the Spearman correlation coefficient (r). 
ap  0.001; bp  0.01; cp  0.05.
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FIG. 2. Correlation between IL8 gene expression in blood peripheral mononuclear cells after nutritional intervention and
changes in body fat mass after weight loss. Data show that lower IL8 transcripts were related to higher decrease in body
fat mass induced by LCD.
instead of fat biopsies, to perform nutrigenomics studies in
obese subjects, and with the additional advantage that this
sample type could be a source of information about the ox-
idative stress and inflammatory status, which are both in-
creased in obesity and its complications (Vincent and Tay-
lor, 2006).
In the context of obesity treatment, dietary interventions
such as caloric restriction diets remain the most efficient ther-
apeutic approach to promote weight loss in obese subjects
(Abete et al., 2006). Moreover, hypocaloric diets have been
proposed to empower the oxidative stress improvement re-
lated to weight loss through a reduction in lipid peroxida-
tion (Crujeiras et al., 2006, 2007). Global gene expression pro-
filing in PBMC, performed in the current work by using
DNA microarrays, revealed that a 8-week LCD devised to
lose weight is able to modulate a wide variety of biological
processes, such as macronutrient metabolism, coagulation,
immune response, and oxidative phosphorylation. The first
step in this study shows that several PBMC biological pro-
cesses could be regulated in the same direction that in adi-
pose tissue after nutritional intervention in obesity (Viguerie
et al., 2005a, 2005b). For example, the genes related to signal
transduction, cell–cell signaling, and immune response, to-
gether with genes associated with insulin sensitivity such as
TNF-/NF-B signal cascade pathway were mostly down-
regulated by caloric restriction. Conversely, protein–DNA
assembly complex and biosynthetic and metabolic regula-
tion processes were upregulated (Clement et al., 2004;
Higami et al., 2004; Viguerie et al., 2005a, 2005b). In addi-
tion, most of changes in gene expression found in this study,
were between of the range (overexpressed: 1.2–2.9; down-
regulated: 0.8–0.4) previously reported in adipose tissue af-
ter 28 day very LCD (Clement et al., 2004).
Some genes also modulated by the nutritional interven-
tion, such as SIRT2 (sirtuin), GHRL (ghrelin), and RPB2
(retinol binding protein 2) are, as far as we know, described
in PBMC for the first time.
Further validation by qRT-PCR confirmed that some key
genes involved in the TNF- and the nuclear factor NF-B
signal cascade pathway, such as RIPK3 (receptor-interacting
serine–threonine kinase 3) and TNIP1 (TNF--induced pro-
tein 3 interacting protein 1) were downregulated by a LCD.
RIPK3 is a family member of the receptor-interacting pro-
teins implicated in activation of NF-B and induction of
apoptosis (Yang et al., 2005) and TNIP1, also known as Naf1,
can inhibit NF-B-dependent gene expression (Gallagher et
al., 2003). These findings are in agreement with reports from
human adipose tissue, which showed an improvement in the
inflammatory profile induced by caloric restriction (Clement
et al., 2004).
Also, other important genes related to oxidative phos-
phorylation, the main source of free radicals (Finkel and Hol-
brook, 2000), such as NDUFS2 (NADH-coenzyme Q reduc-
tase), were downregulated by the nutritional intervention,
suggesting a possible mitochondrial adaptation that could
trigger a decrease in reactive oxygen species production, as
has been shown after caloric restriction in rat liver studies
(Ayala et al., 2007) and human muscle biopsies (Civitarese
et al., 2007).
Therefore, our results suggest a beneficial effect induced
by weight loss or negative energy balance on the TNF-/NF-
B signaling cascade and in oxidative stress, which are both
associated with obesity and insulin resistance (Dandona et
al., 2005). Reinforcing these findings, the body weight ap-
pears to regulate the expression of some genes, such as TNIP,
TANK, TRIAD3, ACAA2, and NDUFS2, as shown by the cor-
relation analyses, suggesting that these genes could be good
markers of body weight in PBMC, despite the fact that a cor-
relation between the gene expression and the diet-induced
changes in the body weight was not detected. However, it
should not be discarded that not only weight loss but also
the negative energy balance could have influenced in the reg-
ulation of these genes. Caloric restriction by itself has been
suggested to regulate adipose tissue gene expression inde-
pendently of the fat mass loss (Viguerie et al., 2005a).
Interestingly, the expression of IL8 (Interleukin 8), a proin-
flammatory cytokine regulated by reactive oxygen interme-
diates (DeForge et al., 1993; Lekstrom-Himes et al., 2005),
tended to be downregulated in PBMC after weight loss in-
duced by caloric restriction. This decrease in IL8 expression
was closely associated to the LCD-induced reduction in body
fat mass, suggesting that it could be a good indicator of vari-
ations in body fat percentage. This finding supports previ-
ous work indicating a upregulation of IL8 gene expression
in preadipocytes of obese subjects (Nair et al., 2005), as well
as studies that show a decrease in the adipose tissue IL8 se-
cretion in humans treated following a hypocaloric diets
(Arvidsson et al., 2004). 
Summing up, the current study demonstrates the applic-
ability of circulating mononuclear cells in the search of tran-
scriptional biomarkers in the context of body weight regu-
lation and nutritional treatments. Moreover, we report for
the first time, the differential expression profile of oxidative
stress and inflammation related genes in these cells under a
model of weight loss induced by an LCD, which is of par-
ticular relevance given the current view of obesity as a low-
degree proinflammatory disease (Moreno-Aliaga et al., 2005;
Vincent and Taylor, 2006). In addition, the IL8 gene expres-
sion in PBMC could be proposed as a possible biomarker for
obesity treatment outcome, given the relationship found be-
tween the decrease in body fat mass and IL8 transcripts.
However, this finding should be corroborated in a future
studies.
Therefore, gene expression in PBMC could be used for di-
agnosis and development of therapeutic strategies in obe-
sity, and could be applied in a more personalized nutritional
approach based on nutrigenomics studies.
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